Circassia Plunks Down $376M For 2 Asthma Treatment Cos.
Allergy-focused Circassia Pharmaceuticals PLC said Friday it's expanding into asthma products with the purchase of Swedish medical diagnostics company Aerocrine AB and clinical-stage-drug maker Prosonix Ltd for a total of £239...To view the full article, register now.
Already a subscriber? Click here to view full article